S&P 500   3,967.08 (+0.46%)
DOW   32,213.36 (+0.34%)
QQQ   309.62 (-0.04%)
AAPL   159.50 (+0.36%)
MSFT   278.92 (+0.45%)
META   205.33 (+0.51%)
GOOGL   104.93 (-0.63%)
AMZN   97.74 (-0.98%)
TSLA   190.10 (-1.10%)
NVDA   265.78 (-2.25%)
NIO   9.03 (-2.59%)
BABA   86.61 (+0.10%)
AMD   97.61 (-2.66%)
T   18.59 (+0.70%)
F   11.43 (+0.09%)
MU   60.71 (-1.03%)
CGC   1.91 (+0.21%)
GE   90.89 (-0.76%)
DIS   93.83 (-2.09%)
AMC   4.48 (+0.22%)
PFE   40.27 (+0.22%)
PYPL   73.28 (+0.99%)
NFLX   328.55 (+2.55%)
S&P 500   3,967.08 (+0.46%)
DOW   32,213.36 (+0.34%)
QQQ   309.62 (-0.04%)
AAPL   159.50 (+0.36%)
MSFT   278.92 (+0.45%)
META   205.33 (+0.51%)
GOOGL   104.93 (-0.63%)
AMZN   97.74 (-0.98%)
TSLA   190.10 (-1.10%)
NVDA   265.78 (-2.25%)
NIO   9.03 (-2.59%)
BABA   86.61 (+0.10%)
AMD   97.61 (-2.66%)
T   18.59 (+0.70%)
F   11.43 (+0.09%)
MU   60.71 (-1.03%)
CGC   1.91 (+0.21%)
GE   90.89 (-0.76%)
DIS   93.83 (-2.09%)
AMC   4.48 (+0.22%)
PFE   40.27 (+0.22%)
PYPL   73.28 (+0.99%)
NFLX   328.55 (+2.55%)
S&P 500   3,967.08 (+0.46%)
DOW   32,213.36 (+0.34%)
QQQ   309.62 (-0.04%)
AAPL   159.50 (+0.36%)
MSFT   278.92 (+0.45%)
META   205.33 (+0.51%)
GOOGL   104.93 (-0.63%)
AMZN   97.74 (-0.98%)
TSLA   190.10 (-1.10%)
NVDA   265.78 (-2.25%)
NIO   9.03 (-2.59%)
BABA   86.61 (+0.10%)
AMD   97.61 (-2.66%)
T   18.59 (+0.70%)
F   11.43 (+0.09%)
MU   60.71 (-1.03%)
CGC   1.91 (+0.21%)
GE   90.89 (-0.76%)
DIS   93.83 (-2.09%)
AMC   4.48 (+0.22%)
PFE   40.27 (+0.22%)
PYPL   73.28 (+0.99%)
NFLX   328.55 (+2.55%)
S&P 500   3,967.08 (+0.46%)
DOW   32,213.36 (+0.34%)
QQQ   309.62 (-0.04%)
AAPL   159.50 (+0.36%)
MSFT   278.92 (+0.45%)
META   205.33 (+0.51%)
GOOGL   104.93 (-0.63%)
AMZN   97.74 (-0.98%)
TSLA   190.10 (-1.10%)
NVDA   265.78 (-2.25%)
NIO   9.03 (-2.59%)
BABA   86.61 (+0.10%)
AMD   97.61 (-2.66%)
T   18.59 (+0.70%)
F   11.43 (+0.09%)
MU   60.71 (-1.03%)
CGC   1.91 (+0.21%)
GE   90.89 (-0.76%)
DIS   93.83 (-2.09%)
AMC   4.48 (+0.22%)
PFE   40.27 (+0.22%)
PYPL   73.28 (+0.99%)
NFLX   328.55 (+2.55%)
NASDAQ:BLFS

BioLife Solutions - BLFS Earnings Date, Estimates & Call Transcripts

$21.30
-0.22 (-1.02%)
(As of 03/24/2023 03:14 PM ET)
Add
Compare
Today's Range
$21.22
▼
$21.80
50-Day Range
$19.50
▼
$26.07
52-Week Range
$10.40
▼
$26.96
Volume
201,427 shs
Average Volume
329,364 shs
Market Capitalization
$911.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$30.00
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

BLFS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BLFS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BioLife Solutions Analyst Forecasts

Current Year EPS Consensus Estimate: $-0.43 EPS
Next Year EPS Consensus Estimate: $0.2 EPS

BLFS Earnings Date and Information

BioLife Solutions has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 8th, 2023 based off prior year's report dates.

BioLife Solutions Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/8/2023
(Estimated)		        
11/9/2022Q3 2022($0.12)($0.15)($0.03)($0.07)$41.63 million$40.75 million
8/9/2022Q2 2022($0.19)($0.13)+$0.06$1.45$39.11 million$40.53 million
5/9/2022Q1 2022($0.13)($0.19)($0.06)($0.21)$37.87 million$36.22 million    
2/28/2022Q4 2021($0.07)($0.32)($0.25)($0.27)$37.28 million$37.30 million    
11/11/20219/30/2021$0.02($0.19)($0.21)($0.38)$31.65 million$33.80 million    
8/11/20216/30/2021$0.03($0.12)($0.15)($0.19)$28.32 million$31.20 million    
5/12/20213/31/2021($0.01)($0.03)($0.02)$0.05$15.60 million$16.85 million  
3/21/202112/31/2020($0.02)($0.06)($0.04)$0.04$13.43 million$14.73 million  
11/5/2020Q3 2020($0.02)($0.02)$10.71 million$11.28 million
8/6/2020Q2 2020($0.01)($0.01)$0.68$9.68 million$9.92 million
5/14/2020Q1 2020$0.06+$0.06$0.13$12.09 million$12.16 million
3/11/202012/31/2019($0.02)$0.02+$0.04($0.02)$8.72 million$8.30 million  
11/12/2019Q3 2019$0.01$0.01($0.35)$7.65 million$6.60 million
8/8/2019Q2 2019$0.02$0.0416+$0.0216$0.05$6.59 million$6.70 million
5/9/20193/31/2019$0.03$0.03$0.04$5.67 million$5.77 million
3/14/2019Q4$0.04$0.04$0.04$5.47 million$5.46 million
11/8/20189/30/2018$0.04$0.05+$0.01$0.05$5.19 million$5.29 million  
8/9/2018Q2 2018$0.04$0.05+$0.01$0.05$5.20 million$5.18 million
5/10/2018Q1 2018$0.0070($0.01)($0.0170)($0.01)$3.81 million$3.82 million
3/8/2018Q4 2017($0.0350)($0.05)($0.0150)($0.05)$3.10 million$3.13 million  
11/9/2017Q3 2017($0.06)($0.03)+$0.03($0.03)$2.60 million$2.96 million
8/10/2017Q2 2017($0.06)($0.06)($0.06)$2.40 million$2.56 million
5/11/2017Q1 2017($0.05)($0.07)($0.02)($0.07)$2.10 million$2.37 million
3/9/2017Q4 2016($0.07)($0.04)+$0.03$0.18$2.20 million$2.25 million  
11/10/2016Q316($0.08)($0.08)($0.08)$2.20 million$2.10 million
8/11/2016Q216($0.09)($0.11)($0.02)($0.11)$2.01 million$2.00 million  
5/12/2016Q1($0.08)($0.10)($0.02)($0.10)$2.20 million$1.85 million  
2/25/2016Q415($0.11)($0.09)+$0.02($0.09)$1.66 million$1.82 million  
11/12/2015Q315($0.10)($0.09)+$0.01($0.09)$1.67 million$1.60 million
8/6/2015Q215($0.10)($0.08)+$0.02($0.08)$1.60 million$1.50 million
5/7/2015Q1 2015($0.09)($0.09)($0.09)$1.47 million$1.50 million
3/12/2015Q4 2014($0.08)($0.08)($0.08)$1.76 million$1.67 million
11/6/2014Q3 2014($0.07)($0.07)($0.07)$1.24 million$1.24 million
8/7/2014Q2 2014($0.05)($0.07)($0.02)($0.07)$1.30 million$1.21 million  
5/8/2014Q1 2014$0.01($0.10)($0.11)($0.10)$2.33 million$2.07 million
2/12/2014Q4 2013($0.07)($0.10)($0.03)($0.10)$2.34 million$2.29 million
4/1/2013Q4 2012($0.14)($0.14)($0.14)
11/13/2012Q3 2012($0.14)($0.14)($0.14)
8/14/2012Q2 2012($0.14)($0.10)+$0.04($0.10)
5/14/2012Q1 2012($0.06)($0.06)($0.06)
3/26/2012Q4 2011($0.08)($0.08)($0.08)
11/14/2011Q3 2011($0.10)($0.10)($0.10)
8/12/2011Q2 2011($0.08)($0.08)($0.08)
5/16/2011Q1 2011($0.13)($0.13)($0.13)
11/10/2008Q3 2008($0.14)($0.14)($0.14)












BioLife Solutions Earnings - Frequently Asked Questions

When is BioLife Solutions's earnings date?

BioLife Solutions has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 8th, 2023 based off last year's report dates. Learn more on BLFS's earnings history.

How much revenue does BioLife Solutions generate each year?

BioLife Solutions (NASDAQ:BLFS) has a recorded annual revenue of $161.76 million.

How much profit does BioLife Solutions generate each year?

BioLife Solutions (NASDAQ:BLFS) has a recorded net income of -$149.85 million. BLFS has generated -$3.26 earnings per share over the last four quarters.

What is BioLife Solutions's EPS forecast for next year?

BioLife Solutions's earnings are expected to grow from ($0.43) per share to $0.20 per share in the next year.

More Earnings Resources from MarketBeat

Earnings Tools:
Earnings By Country:
Latest Articles:
Upcoming Earnings:
This page (NASDAQ:BLFS) was last updated on 3/24/2023 by MarketBeat.com Staff